English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/218666
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:

Title

Vitamin D effects on cell differentiation and stemness in cancer

AuthorsFernández-Barral, A. ; Bustamante-Madrid, Pilar; Ferrer-Mayorga, Gemma ; Barbáchano, Antonio ; Larriba, María Jesús ; Muñoz Terol, Alberto
KeywordsVitamin D
Cell differentiation
Stemness
Cancer-associated fibroblasts
Cancer
Carcinoma cells
Issue Date2020
PublisherMultidisciplinary Digital Publishing Institute
CitationCancers 12(9): 2413 (2020)
AbstractVitamin D3 is the precursor of 1α,25-dihydroxyvitamin D3 (1,25(OH)2D3), a pleiotropic hormone that is a major regulator of the human genome. 1,25(OH)2D3 modulates the phenotype and physiology of many cell types by controlling the expression of hundreds of genes in a tissue- and cell-specific fashion. Vitamin D deficiency is common among cancer patients and numerous studies have reported that 1,25(OH)2D3 promotes the differentiation of a wide panel of cultured carcinoma cells, frequently associated with a reduction in cell proliferation and survival. A major mechanism of this action is inhibition of the epithelial–mesenchymal transition, which in turn is largely based on antagonism of the Wnt/β-catenin, TGF-β and EGF signaling pathways. In addition, 1,25(OH)2D3 controls the gene expression profile and phenotype of cancer-associated fibroblasts (CAFs), which are important players in the tumorigenic process. Moreover, recent data suggest a regulatory role of 1,25(OH)2D3 in the biology of normal and cancer stem cells (CSCs). Here, we revise the current knowledge of the molecular and genetic basis of the regulation by 1,25(OH)2D3 of the differentiation and stemness of human carcinoma cells, CAFs and CSCs. These effects support a homeostatic non-cytotoxic anticancer action of 1,25(OH)2D3 based on reprogramming of the phenotype of several cell types.
DescriptionThis article belongs to the Special Issue Stemness and Differentiation in Cancer.
Publisher version (URL)https://doi.org/10.3390/cancers12092413
URIhttp://hdl.handle.net/10261/218666
DOIhttp://dx.doi.org/10.3390/cancers12092413
E-ISSN2072-6694
Appears in Collections:(IIBM) Artículos
Files in This Item:
File Description SizeFormat 
vitaDstemcance.pdf1,16 MBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.